Exome Asset Management »

Centessa Pharmaceuticals shares owned by Exome Asset Management

Quarter-by-quarter ownership of Centessa Pharmaceuticals shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $606k 25k 24.25

More positions owned by Exome Asset Management

Ionis Pharmaceuticals (IONS)
Cytokinetics Com New (CYTK)
Bridgebio Pharma (BBIO)
Cogent Biosciences (COGT)
Guardant Health (GH)
Eli Lilly & Co. (LLY)
I Mab Sponsored Ads (IMAB)
Praxis Precision Medicines I Com New (PRAX)
Vera Therapeutics Cl A (VERA)
Astrazeneca Sponsored Adr (AZN)
Disc Medicine (IRON)
89bio (ETNB)
Apogee Therapeutics (APGE)
Travere Therapeutics (TVTX)
Tenet Healthcare Corp Com New (THC)

View all positions for Exome Asset Management

Top funds holding Centessa Pharmaceuticals

Simplex Trading
Exome Asset Management
Group One Trading

View all funds holding Centessa Pharmaceuticals